Dimethyl Fumarate Capsule, Delayed Release
Product Images NDC 82009-138

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 82009-138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

240mg-60s-carton (240mg 60s Carton)

This is a medication label for Dimethyl Fumarate Delayed-Release Capsules, each containing 240 mg of dimethyl fumarate. The usual dosage is to take one capsule by mouth twice a day. This medication should be stored at 20° to 25°C and protected from light. The contact number for the U.S. is provided for any inquiries. The medication is dispensed in an original package and should be swallowed whole. Manufacturing and licensing information is also included on the label.*

FDA Label Image

240mg-60s-container (240mg 60s Container)

This is a description of Dimethyl Fumarate delayed-release capsules, with each capsule containing 240mg of dimethyl fumarate. The usual dosage is one capsule taken by mouth twice a day. The capsules should be swallowed whole and stored in the original container at 20° to 25°C. The pharmaceutical product is manufactured by Quallent Pharmaceuticals Health LLG in the Cayman Islands, and contact information is provided.*

FDA Label Image

Dimethylfumaratedrcapfigure1 (Dimethylfumaratedrcapfigure1)

FDA Label Image

Dimethylfumaratestructure (Dimethylfumaratestructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.